MacroGenics Inc (NASDAQ:MGNX)

6.68
Delayed Data
As of Mar 24
 -0.275 / -3.96%
Today’s Change
2.13
Today|||52-Week Range
10.20
-0.52%
Year-to-Date
Why MacroGenics Stock Inched Higher on Monday
Mar 20 / MotleyFool.com - Paid Partner Content
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript
Mar 15 / MotleyFool.com - Paid Partner Content
Why MacroGenics Stock Tumbled Today
Mar 17 / MotleyFool.com - Paid Partner Content
MacroGenics (MGNX) Surpasses Q4 Earnings Estimates
Mar 15 / Zacks.com - Paid Partner Content
Why Shares of MacroGenics Climbed Thursday
Mar 16 / MotleyFool.com - Paid Partner Content
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi
Mar 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.95
Today’s open6.95
Day’s range6.65 - 6.95
Volume11,916
Average volume (3 months)776,910
Market cap$429.2M
Data as of 3:59pm ET, 03/24/2023

Growth & Valuation

Earnings growth (last year)+42.18%
Earnings growth (this year)+36.92%
Earnings growth (next 5 years)--
Revenue growth (last year)+96.19%
P/E ratioNM
Price/Sales2.71
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
ARCTArcturus Therapeutic...+0.63+4.17%
--Tempo Scan Pacific T...0.000.00%
AMRXAmneal Pharmaceutica...+0.03+2.29%
----
Data as of 3:59pm ET, 03/24/2023

Financials

Next reporting dateMay 9, 2023
EPS forecast (this quarter)$0.58
Annual revenue (last year)$151.9M
Annual profit (last year)-$119.8M
Net profit margin-78.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts